EUVIMEDEUVIMED entdecken
Crossref

Exploring the Role of Hypusine Signaling in Vascular Smooth Muscle Cells for Mitigating Restenosis in Coronary Artery Disease

Yann Grobs iD, Sarah-Eve Lemay iD, Manon Mougin iD, Charlie Thberge, Magalie Boucher, Sandra Breuils-Bonnet iD, Sandra Martineau iD, Alice Bourgeois, Andreanne Pelletier, Maud Fillon, Jean Perron iD, François Potus iD und 3 weitere

Arteriosclerosis, Thrombosis, and Vascular Biology · 2026

DOI: 10.1161/atvbaha.126.324325 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2026. Verfasst von Yann Grobs und 14 weiteren Autor:innen. Beteiligte Einrichtung: Pulmonary Hypertension Research Group, Centre de Recherche Universitaire de Cardiologie et de Pneumologie de Québec, Canada (Y.G., S.-E.L., M.M., C.T…. Hauptthemen laut MEDLINE: Muscle, Smooth, Vascular, Myocytes, Smooth Muscle, Coronary Restenosis, Coronary Artery Disease. Die Arbeit nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Post-surgical restenosis in patients with coronary artery disease (CAD) is a pathological vascular remodeling process characterized by neointimal hyperplasia, which is mainly driven by phenotypic switching of vascular smooth muscle cells toward a synthetic and proliferative state. This study investigated a novel signaling pathway to promote the proproliferative phenotype of vascular smooth muscle cells and contribute to the neointimal hyperplasia development. METHODS: Using comparative proteomic analysis and Western blotting, expression of hypusine signaling components was evaluated in human primary cultures of coronary artery smooth muscle cells isolated from controls and patients with CAD, as well as in 3 preclinical animal models of restenosis: rat carotid injury, mouse carotid ligation, and canine coronary artery bypass graft. CAD-coronary artery smooth muscle cell proliferation was assessed by Western blot and immunofluorescence with pharmacological (N1-guanyl-1,7-diaminoheptane) and molecular (shRNA) inhibitors of DHPS (deoxyhypusine synthase). The contribution of hypusine signaling to neointimal hyperplasia was investigated using both pharmacological and genetic approaches. In addition, human saphenous vein and human coronary artery tissue cultures were used to explore the translational potential of targeting hypusine signaling to prevent neointimal hyperplasia. RESULTS: All components of the hypusine pathway (eIF5A (eukaryotic translation initiation factor 5A), DOHH (deoxyhypusine hydroxylase), and DHPS were significantly overexpressed in CAD-coronary artery smooth muscle cells and in preclinical animal models of restenosis. Pharmacological and molecular inhibition of DHPS reduced eIF5A hypusination, vascular smooth muscle cell proliferation, and expression of ECM (extracellular matrix) proteins. Proteomic and KEGG (Kyoto Encyclopedia of Genes and Genomes) analyses demonstrated disruption of cell-cycle and DNA replication pathways, including a downregulation of TTK (threonine tyrosine kinase). Our findings suggest that TTK acts as a downstream effector of hypusine signaling, which partly mediates the proliferative effects observed in CAD-coronary artery smooth muscle cells. In vivo, pharmacological and smooth muscle cell–targeted inactivation of DHPS significantly reduced neointimal hyperplasia without adverse effects. Finally, ex vivo human tissue culture confirmed that N1-guanyl-1,7-diaminoheptane mitigates growth factor–induced vascular remodeling. CONCLUSIONS: Hypusine signaling is a critical regulator of vascular smooth muscle cell proliferation for neointimal hyperplasia. Inhibiting DHPS reduces vascular remodeling, making it a promising target for preventing restenosis after coronary interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscle, Smooth, VascularMyocytes, Smooth MuscleCoronary RestenosisCoronary Artery DiseaseAnimalsHumansSignal TransductionCells, CulturedNeointimaCell ProliferationDisease Models, AnimalHyperplasiaDogsMaleCoronary VesselsProteomicsRats, Sprague-DawleyMice, Inbred C57BLCarotid Artery InjuriesFemaleMiddle AgedRatsAgedPhenotype

Stichwörter der Autor:innen

cardiovascular diseasesdrug-eluting stentshyperplasiamuscle, smooth, vascularvascular system injuries

Autor:innen und Institutionen

  • Pulmonary Hypertension Research Group, Centre de Recherche Universitaire de Cardiologie et de Pneumologie de Québec, Canada (Y.G., S.-E.L., M.M., C.T., M.B., S.B.-B., S.M., A.B., A.P., M.F., J.P., F.P., S.P., O.B., S.B.…
  • Institute for Lung Health, Cardio-Pulmonary Institute, Member of the German Center for Lung Research (DZL), Giessen, Germany (S.B.).

ORCID-Profile: Yann Grobs, Sarah-Eve Lemay, Manon Mougin, Sandra Breuils-Bonnet, Sandra Martineau, Jean Perron, François Potus, Steeve Provencher, Olivier Boucherat, Sebastien Bonnet

Zitieren

APA

Grobs, Y., Lemay, S. E., Mougin, M., Thberge, C., Boucher, M., Breuils-Bonnet, S., Martineau, S., Bourgeois, A., Pelletier, A., Fillon, M., Perron, J., Potus, F., Provencher, S., Boucherat, O., & Bonnet, S. (2026). Exploring the Role of Hypusine Signaling in Vascular Smooth Muscle Cells for Mitigating Restenosis in Coronary Artery Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.126.324325

Vancouver

Grobs Y, Lemay SE, Mougin M, Thberge C, Boucher M, Breuils-Bonnet S, et al. Exploring the Role of Hypusine Signaling in Vascular Smooth Muscle Cells for Mitigating Restenosis in Coronary Artery Disease. Arteriosclerosis, Thrombosis, and Vascular Biology. 2026. doi:10.1161/atvbaha.126.324325

BibTeX
@article{Grobs2026,
  author = {Grobs, Yann and Lemay, Sarah-Eve and Mougin, Manon and Thberge, Charlie and Boucher, Magalie and Breuils-Bonnet, Sandra and Martineau, Sandra and Bourgeois, Alice and Pelletier, Andreanne and Fillon, Maud and Perron, Jean and Potus, François and Provencher, Steeve and Boucherat, Olivier and Bonnet, Sebastien},
  title = {Exploring the Role of Hypusine Signaling in Vascular Smooth Muscle Cells for Mitigating Restenosis in Coronary Artery Disease},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2026},
  doi = {10.1161/atvbaha.126.324325}
}
Kostenlos starten →